Advanced Enzyme’s arm inks definitive pact with Evoxx Technologies

27 Jul 2017 Evaluate

Advanced Enzyme Technologies’ wholly owned subsidiary, Advanced Enzymes Europe B.V. based in Amsterdam (Netherlands) has signed a Definitive Agreement on July 26, 2017 with Evoxx Technologies GmbH, a company based in Germany and all the shareholders of Evoxx to acquire 100% shareholding (i.e. 164,031 shares) in Evoxx for a total consideration of Euro 7.65 Million. The acquisition is expected to be completed by mid of August 2017.

On completion of the aforesaid acquisition, Evoxx will become direct subsidiary of Advanced Enzymes Europe B.V. and indirect subsidiary of Advance Enzyme Technologies.

Advanced Enzyme Technologies is an India based company engaged in research, development, manufacturing and marketing of Healthcare, Nutrition and Bio-Processing products.

Advanced Enzyme Share Price

289.40 -6.55 (-2.21%)
29-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1717.50
Dr. Reddys Lab 1268.60
Cipla 1494.40
Zydus Lifesciences 904.00
Lupin 2079.50
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×